V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10006911 | 10008540 | 1.84 | 91 | Curative (C) | 2015-05-16 | 2015-06-10 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | 10480843 | ENZALUTAMIDE |
| 10006912 | 10004759 | 1.84 | 79 | Curative (C) | 2016-06-08 | 2016-06-28 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 10480861 | CYCLOPHOSPHAMIDE |
| 10006913 | 10004761 | 1.77 | 79.6 | Palliative (P) | 2017-12-31 | 2018-12-19 | Bortezomib +/- Dexamethasone | N | N | 10480916 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 10006914 | 10004761 | 1.8 | 70.8 | Adjuvant (A) | 2017-06-19 | 2017-06-26 | CARBO + FLUOROURACIL | N | N | 10480916 | IRINOTECAN + MDG + PANITUMUMAB |
| 10006915 | 10004762 | 1.65 | 88.25 | Palliative (P) | null | 2019-02-14 | CARBO + FLUOROURACIL | N | N | 10481004 | CAPECITABINE + CISPLATIN + RT |
| 10006916 | 10004763 | 1.7 | 110.9 | Curative (C) | 2018-09-02 | 2018-09-03 | CISPLATIN + FLUOROURACIL | N | N | 10481040 | BENDAMUSTINE |
| 10006917 | 10004765 | 1.5 | null | Palliative (P) | 2017-07-12 | 2017-08-03 | Trifluridine + Tipiracil | N | N | 10481116 | CAPECITABINE + IRINOTECAN |
| 10006918 | 10004766 | 1.8 | 60.1 | Palliative (P) | null | 2017-03-28 | MaxiCHOP (>Cycle 2) | N | N | 10481193 | CISPLATIN + ETOPOSIDE |
| 10006919 | 10004767 | 1.81 | null | Palliative (P) | 2014-01-31 | 2014-02-06 | Cyclophosphamide oral | N | N | 10481271 | PIXANTRONE |
| 10006920 | 10004768 | null | 79.6 | Palliative (P) | 2017-11-30 | 2017-11-30 | Cetuximab 14 day | N | N | 10481342 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 10006921 | 10004770 | null | null | Curative (C) | null | 2017-03-10 | Cisplatin | N | null | 10481342 | CAPECITABINE + IRINOTECAN |
| 10006922 | 10004771 | 1.66 | 73.3 | Adjuvant (A) | 2017-07-03 | 2017-07-03 | Capecitabine (14 day) + Irinotecan | 2 | Y | 10481461 | PAZOPANIB |
| 10006923 | 10007411 | null | 74.4 | Palliative (P) | 2018-09-24 | 2018-10-21 | Cytarabine + Idarubicin | 2 | N | 10481483 | VEPEMB |
| 10006924 | 10004774 | 1.75 | 64 | Curative (C) | 2016-05-25 | 2016-05-26 | Capecitabine (14 day) + Irinotecan | 2 | N | 10481596 | CAPECITABINE + IRINOTECAN |
| 10006925 | 10004776 | 1.74 | 70 | null | 2016-03-25 | 2016-04-08 | Cetuximab 7 day (>Cycle 2) | 2 | N | 10481596 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 10006926 | 10004776 | 1.75 | 62 | Curative (C) | 2016-05-11 | 2016-06-15 | INCA TRIAL | N | N | 10481596 | IBRUTINIB + RITUXIMAB |
| 10006927 | 10004777 | 1.7 | 71 | Not known (9) | 2017-02-24 | 2017-06-16 | Cytarabine + Idarubicin | 02 | N | 10481844 | HYDROXYCARBAMIDE |
| 10006928 | 10004778 | 0 | 86.4 | Curative (C) | 2017-09-01 | 2017-09-01 | VEDex | N | null | 10481844 | CHLORAMBUCIL + OBINUTUZUMAB |
| 10006929 | 10004778 | 1.76 | 81 | Curative (C) | 2017-10-03 | 2017-10-03 | Gemcitabine + Paclitaxel | 2 | N | 10481844 | VINORELBINE |
| 10006930 | 10004778 | 1.61 | 71 | Palliative (P) | 2015-05-03 | 2015-05-10 | DABRAFENIB + TRAMETINIB | N | N | 10481844 | RUXOLITINIB |
| 10006931 | 10004780 | 1.77 | 0 | Palliative (P) | null | 2018-05-14 | EOX | N | N | 10482137 | CETUXIMAB + RT |
| 10006932 | 10004780 | 1.62 | null | Curative (C) | 2017-08-20 | 2017-08-20 | Busulfan Oral | N | N | 10482137 | STAMPEDE TRIAL |
| 10006933 | 10004781 | 1.64 | null | null | 2018-08-16 | 2018-08-16 | Carboplatin + Liposomal Doxorubicin | 1 | N | 10482223 | CISPLATIN + VINORELBINE |
| 10006934 | 10004781 | 1.67 | 84.2 | Curative (C) | 2016-11-23 | 2016-11-24 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | 10482223 | FCR |
| 10006935 | 10007416 | 1.79 | 57 | Palliative (P) | 2018-10-04 | 2018-12-17 | NIVOLUMAB | N | N | 10482327 | ALEMTUZUMAB |
| 10006936 | 10004785 | 1.82 | 92.4 | Palliative (P) | 2017-04-22 | 2017-04-24 | MYELOMA XI TRIAL | 02 | N | 10482674 | BOSUTINIB |
| 10006937 | 10004786 | 1.57 | 74 | Palliative (P) | 2016-12-23 | 2016-12-23 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 10482818 | TRASTUZUMAB EMTANSINE |
| 10006938 | 10004787 | 1.65 | 76.9 | Palliative (P) | 2016-05-27 | 2016-06-23 | Cisplatin + Etoposide po&iv 3 day | N | N | 10482890 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 10006939 | 10004788 | null | 61 | Curative (C) | 2014-06-23 | 2014-07-22 | CISPLATIN + VINORELBINE + RT | N | N | 10482982 | CLADRIBINE |
| 10006940 | 10007418 | 1.65 | 67.4 | Curative (C) | null | 2017-04-03 | OCTREOTIDE | Y | null | 10482982 | CAP + RT |
| 10006941 | 10007418 | 1.61 | null | null | 2016-09-06 | 2016-10-05 | FEC | N | N | 10482982 | CYCLOPHOSPHAMIDE + DOCETAXEL + TRASTUZUMAB |
| 10006942 | 10004789 | 1.63 | 93 | Palliative (P) | null | 2017-07-11 | LEAM | N | N | 10483298 | ERLOTINIB |
| 10006943 | 10004790 | 1.72 | 94.9 | Palliative (P) | 2018-01-14 | 2018-01-23 | BENDAMUSTINE | 2 | N | 10483528 | HCX |
| 10006944 | 10004791 | 1.67 | 95 | Palliative (P) | 2017-01-03 | 2017-01-08 | GDP | 02 | N | 10483623 | BRENTUXIMAB |
| 10006945 | 10004792 | 1.63 | 81.5 | Adjuvant (A) | 2014-11-28 | 2014-11-28 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | N | 10483625 | CETUXIMAB |
| 10006946 | 10004793 | 1.58 | 65.6 | Not known (9) | 2015-03-04 | 2015-04-03 | CARBOPLATIN + PACLITAXEL + RT | N | N | 10483645 | CETUXIMAB + IRINOTECAN + MDG |
| 10006947 | 10004794 | null | 65.5 | Palliative (P) | 2014-03-15 | 2014-03-20 | FLAIR Trial | 2 | null | 10483645 | FLUOROURACIL + MITOMYCIN |
| 10006948 | 10004796 | 1.67 | null | Palliative (P) | 2018-07-28 | 2018-08-31 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | null | 10483955 | ERLOTINIB |
| 10006949 | 10007421 | 1.78 | 83 | Palliative (P) | 2018-11-29 | 2019-02-07 | ENRICH Trial | N | N | 10483976 | OXALIPLATIN |
| 10006950 | 10004797 | 1.75 | 71.4 | Palliative (P) | 2016-06-01 | 2016-09-27 | Methotrexate High Dose (3g/m2) | 1 | N | 10484074 | MELPHALAN |
| 10006951 | 10004798 | 1.67 | 70 | null | 2018-05-05 | 2018-06-10 | CYTARABINE + RITUXIMAB | N | N | 10484074 | MELPHALAN |
| 10006952 | 10004798 | null | 57.9 | Palliative (P) | 2017-03-19 | 2017-04-02 | FEC 100 + DOCETAXEL + TRASTUZUMAB | 02 | N | 10484074 | SUNITINIB |
| 10006953 | 10008550 | 1.7 | 96.8 | Curative (C) | 2016-05-17 | 2016-06-14 | CARMUSTINE + THIOTEPA | N | N | 10484169 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 10006954 | 10004800 | 1.75 | 66 | Adjuvant (A) | 2017-12-21 | 2018-01-13 | Methotrexate intrathecal | N | N | 10484169 | FLUOROURACIL + MITOMYCIN + RT |
| 10006955 | 10004801 | 1.7 | null | Palliative (P) | 2015-06-28 | 2015-07-25 | Liposomal Doxorubicin 40mg/m2 | N | N | 10484257 | VINORELBINE |
| 10006956 | 10004801 | 1.71 | 86 | Palliative (P) | 2015-07-18 | 2016-03-11 | Sunitinib | 02 | N | 10484257 | CAPECITABINE + CARBOPLATIN |
| 10006957 | 10004803 | 1.75 | 79.9 | Palliative (P) | 2015-04-28 | 2015-04-28 | Trifluridine + Tipiracil | 02 | N | 10484414 | POMALIDOMIDE |
| 10006958 | 10007426 | 1.61 | 69 | Curative (C) | 2019-05-04 | 2019-06-03 | Cisplatin + Vinorelbine (IV) | N | N | 10484424 | LIPOSOMAL DOXORUBICIN |
| 10006959 | 10007426 | 1.64 | 99 | Palliative (P) | 2015-12-09 | 2016-01-20 | EC | N | N | 10484424 | ABVD |
| 10006960 | 10004804 | 1.75 | 104.3 | Neo-adjuvant (N) | 2015-12-17 | 2016-12-04 | FLAIR Trial | 2 | N | 10484515 | IPILIMUMAB |